Norges Bank’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-735,900
| Closed | -$1.17M | – | 2044 |
|
|
2023
Q1 | $1.17M | Hold |
735,900
| – | – | ﹤0.01% | 1987 |
|
|
2022
Q4 | $4.58M | Buy |
+735,900
| New | +$4.58M | ﹤0.01% | 1805 |
|
|
2021
Q3 | – | Sell |
-189,931
| Closed | -$4.02M | – | 2295 |
|
|
2021
Q2 | $4.02M | Sell |
189,931
-38,012
| -17% | -$804K | ﹤0.01% | 1936 |
|
|
2021
Q1 | $6.39M | Sell |
227,943
-39,617
| -15% | -$1.11M | ﹤0.01% | 1878 |
|
|
2020
Q4 | $6.96M | Sell |
267,560
-7,192
| -3% | -$187K | ﹤0.01% | 1831 |
|
|
2020
Q3 | $10.2M | Sell |
274,752
-26,021
| -9% | -$967K | ﹤0.01% | 1702 |
|
|
2020
Q2 | $15.4M | Sell |
300,773
-12,796
| -4% | -$657K | ﹤0.01% | 1581 |
|
|
2020
Q1 | $9.89M | Hold |
313,569
| – | – | ﹤0.01% | 1624 |
|
|
2019
Q4 | $18.7M | Hold |
313,569
| – | – | 0.01% | 1553 |
|
|
2019
Q3 | $11.5M | Buy |
313,569
+12,612
| +4% | +$462K | ﹤0.01% | 1726 |
|
|
2019
Q2 | $14M | Buy |
300,957
+134,096
| +80% | +$6.24M | ﹤0.01% | 1676 |
|
|
2019
Q1 | $6.7M | Buy |
166,861
+46,511
| +39% | +$1.87M | ﹤0.01% | 1896 |
|
|
2018
Q4 | $5.54M | Hold |
120,350
| – | – | ﹤0.01% | 1908 |
|
|
2018
Q3 | $5.34M | Hold |
120,350
| – | – | ﹤0.01% | 1960 |
|
|
2018
Q2 | $4.72M | Buy |
120,350
+14,491
| +14% | +$568K | ﹤0.01% | 1961 |
|
|
2018
Q1 | $7.66M | Buy |
+105,859
| New | +$7.66M | ﹤0.01% | 1819 |
|
|
2016
Q2 | – | Sell |
-21,044
| Closed | -$356K | – | 2178 |
|
|
2016
Q1 | $356K | Hold |
21,044
| – | – | ﹤0.01% | 2147 |
|
|
2015
Q4 | $468K | Hold |
21,044
| – | – | ﹤0.01% | 2173 |
|
|
2015
Q3 | $496K | Buy |
+21,044
| New | +$496K | ﹤0.01% | 2189 |
|